Matthew A. Holian

DLA Piper

Articles

Results 1 to 5 of 5
Most popular |Most recent


Global COVID-19 Vaccine Guide for Employers

Global - October 5 2021 As more workers are returning to workplaces and business travel, many employers are considering what their approach should be to issues around…

Ute Krudewagen, Andrew Dyson, Katherine Gibson, Andrew Gilbert, Brian Kaplan, Pilar Menor, Marco de Morpurgo.

Global COVID-19 Vaccine Guide for Employers

Global - May 25 2021 As the scientific response to the COVID-19 pandemic develops, many employers are considering what their approach should be to the issues around…

Ute Krudewagen, Andrew Dyson, Katherine Gibson, Andrew Gilbert, Brian Kaplan, Pilar Menor, Marco de Morpurgo.

Exploring ways to improve MDL management: key takeaways from the MDL Subcommittee biannual session

USA - November 5 2018 Over the past year, the MDL Subcommittee of the Advisory Committee on Civil Rules has held a number of public hearings regarding ways to improve the…

Christopher G. Campbell.

CRISPR technology and evolving scientific data: how biotechnology and pharmaceutical companies can mitigate potential product safety risks

USA - August 16 2018 One of the most exciting, ground-breaking scientific advances developed in the last decade for treating cancer and other diseases is a technology…

Lisa A. Haile, Saher Valiani.

The writing’s on the wall: wise pharma companies will heed FDA warning in new draft guidance on data integrity cGMPs

USA - May 2 2016 FDA is again shining a spotlight on data integrity violations, announcing in a new draft Guidance for Industry: Data Integrity and Compliance with…

James N. Czaban, John M. Hillebrecht, Rebecca Jones McKnight.